Get started
Author

Jingsheng Hua

Innovative Applications of Bacteria and Their Derivatives in Targeted Tumor Therapy
2025 · Denghui Zhu, Wendi Pan, et al. · ACS Nano · 59
Donor-derived anti-CD19 CAR T cells compared with donor lymphocyte infusion for recurrent B-ALL after allogeneic hematopoietic stem cell transplantation
2020 · Jingsheng Hua, Jian Zhang, et al. · Bone Marrow Transplantation · 40
Early Death and Survival of Patients With Acute Promyelocytic Leukemia in ATRA Plus Arsenic Era: A Population-Based Study
2021 · Hong-Hu Zhu, Ya-Fang Ma, et al. · Frontiers in Oncology · 28
Allogeneic Donor-Derived Anti-CD19 CAR T Cell Is a Promising Therapy for Relapsed/Refractory B-ALL After Allogeneic Hematopoietic Stem-Cell Transplantation
2020 · Jingsheng Hua, Jian Zhang, et al. · Clinical Lymphoma Myeloma & Leukemia · 22
Dysfunction of microRNA-32 regulates ubiquitin ligase FBXW7 in multiple myeloma disease
2016 · Jingsheng Hua, Tianling Ding, et al. · OncoTargets and Therapy · 17
PDF
Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature
2020 · Jingsheng Hua, Weiqing Qian, et al. · OncoTargets and Therapy · 13
PDF
A transient receptor potential channel-related model based on machine learning for evaluating tumor microenvironment and immunotherapeutic strategies in acute myeloid leukemia
2022 · Jingsheng Hua, Tianling Ding, et al. · Frontiers in Immunology · 11
Safety and efficacy of PCSK9 inhibitor (evolocumab) in patients with non-ST segment elevation acute coronary syndrome and non-culprit artery critical lesions: a randomised controlled trial protocol (SPECIAL study)
2024 · Yu-Wei Wang, Jie Xu, et al. · BMJ Open · 5
Comprehensive analysis of ERCC3 prognosis value and ceRNA network in AML
2022 · Xiebing Bao, Yao Chen, et al. · Clinical & Translational Oncology · 3
Global, regional, and National burden of metabolic dysfunction-associated steatohepatitis-related liver cancer in older adults: trends and cross-national inequality based on the global burden of disease study 2021
2025 · Weikang Meng, Jingsheng Hua, et al. · Discover Oncology · 2
PDF
High FAAP24 expression reveals poor prognosis and an immunosuppressive microenvironment shaping in AML
2023 · Xiebing Bao, Jingyun Chi, et al. · Cancer Cell International · 2
PDF
A Rare Morphology Resembling APL with t (11;12) (p15;q13) in Acute Myeloid Leukemia: Case Report and Literature Review
2019 · Jingsheng Hua, Xiebin Bao, et al. · Clinical Laboratory · 2
[Comparison of the Curative Efficacy of Elderly Patients with High-Risk MDS and MDS-Transformed AML between Decitabine Combined with Low-Dose CEG Regimen and Decitabine Combined with Low-Dose CAG Regimen].
2020 · Min Wu, Ie-Xian Ma, et al. · 中国实验血液学杂志 · 1
Folate-Conjugated Quaternized Chitosan and Calcium Alginate Layer-by-Layer Nanoparticles: An Oral Platform for Targeted Gene-Immune Synergistic Therapy of Colorectal Cancer
2026 · Yuhong Lin, Meiyi Xin, et al. · Biomacromolecules
Fabrication of cercosporin-loaded polydopamine- cloaked mesoporous silica nanoparticles enhanced photothermal-photodynamic and anticancer activity in pancreatic cancer
2026 · Jingsheng Hua, Bo Ning, et al. · Journal of Materials Science Materials in Medicine
Nanoformulated Curcumin Ameliorates Ulcerative Colitis via Gut Microbiota Modulation and Barrier Function Restoration
2026 · Yin-Zhuo Xie, Chen-Xi Sun, et al. · The American Journal of Chinese Medicine
Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
2025 · Jiani Ge, Yunfan Sun, et al. · Journal of Visualized Experiments
Safety and efficacy of different rotational speed during rotational atherectomy in coronary heart disease patients (RACE): study protocol for a randomized controlled trial
2025 · Jie Xu, Yu-wei Wang, et al. · Trials
PDF
Survival Benefit and Efficiency of Low Dose Decitabine With CEG Regimen Compared to Decitabine Alone in the Elderly MDS – A Multicenter, Retrospective Study
2021 · Jiexian Ma, Youdao Liang, et al. · Clinical Lymphoma Myeloma & Leukemia
Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature [Corrigendum]
2020 · Jingsheng Hua, Weiqing Qian, et al. · OncoTargets and Therapy
PDF
A Novel Combination of Decitabine and Etoposide Greatly Improves the Survival of TP53 Mutation AML/MDS Patients by Targeting Notch1 Signaling Pathway
2020 · Jiexian Ma, Shunrong Sun, et al. · SSRN Electronic Journal
Works count: 21
Citation count: 205
H-index: 7
I10-index: 7
Year
Topic
Type